Results
Mangalam Drugs FY26 Reports ₹44 Crore Consolidated Net Loss
Mangalam Drugs reported a consolidated net loss of ₹44.40 crore for FY26, a significant deterioration from a ₹6.72 crore profit in FY25, driven by a 27% revenue decline due to global funding disruptio
